Melanoma

Showing NaN - NaN of 82

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Pittsburgh (administration of ipilimumab10mg/kg, administration of ipilimumab 3mg/kg + HDI)

Completed
  • Melanoma
  • administration of ipilimumab10mg/kg
  • administration of ipilimumab 3mg/kg + HDI
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 24, 2018

Melanoma Trial in Worldwide (Tasisulam-sodium, Paclitaxel)

Terminated
  • Melanoma
  • Birmingham, Alabama
  • +121 more
Jun 18, 2018

Melanoma Trial in United States (GRN-1201)

Completed
  • Melanoma
  • GRN-1201
  • Cincinnati, Ohio
  • +3 more
Jun 13, 2018

Melanoma Trial in Pittsburgh (High dose bolus interleukin-2 (HD IL2))

Terminated
  • Melanoma
  • High dose bolus interleukin-2 (HD IL2)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center- Hillman Cancer Center
Mar 21, 2018

Atypical Nevi, Melanoma Trial in Pittsburgh (broccoli sprout extract - sulforaphane (BSE-SFN))

Completed
  • Atypical Nevi
  • Melanoma
  • broccoli sprout extract - sulforaphane (BSE-SFN)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 7, 2018

Melanoma Trial in Pittsburgh (ipilimumab)

Completed
  • Melanoma
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center/University of Pittsburgh
Dec 5, 2017

Melanoma, Metastatic Melanoma Trial in United States (Vemurafenib, Bevacizumab, Cobimetinib)

Terminated
  • Melanoma
  • Metastatic Melanoma
  • Los Angeles, California
  • +13 more
Sep 22, 2017

Melanoma Trial in Pittsburgh (Nivolumab - Arm A, Nivolumab + Ipilimumab - Arm B)

Withdrawn
  • Melanoma
  • Nivolumab - Arm A
  • Nivolumab + Ipilimumab - Arm B
  • Pittsburgh, Pennsylvania
    UPMC Cancer Center Hillman Cancer Center
Sep 18, 2017

Melanoma Trial in Pittsburgh (DC Vaccine + IFN, AdVTMM2/DC Vaccination)

Completed
  • Melanoma
  • DC Vaccine + IFN
  • AdVTMM2/DC Vaccination
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Aug 30, 2017

Melanoma Trial in Pittsburgh (IFNa2b, PEG- IFNa2b)

Terminated
  • Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 3, 2017

Melanoma Trial in Australia, United States (SB-485232)

Completed
  • Melanoma
  • Los Angeles, California
  • +19 more
Jul 25, 2017

Melanoma Trial in Pittsburgh (Anti-CTLA4 mAb and HDI)

Completed
  • Melanoma
  • Anti-CTLA4 monoclonal antibody and HDI
  • Pittsburgh, Pennsylvania
    UPCI Hillman Cancer Center
Jun 20, 2017

Prostatic Tumors, Breast Tumors, Colorectal Tumors Trial in United States (Interactive Voice Response (IVR) Reminders)

Completed
  • Prostatic Neoplasms
  • +4 more
  • Interactive Voice Response (IVR) Reminders
  • New Haven, Connecticut
  • +7 more
Jun 6, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Melanoma, Cancer Trial in Canada, United States (ALVAC(2) Melanoma multi-antigen therapeutic vaccine, Intron A, Interferon alpha

Terminated
  • Melanoma
  • Cancer
  • ALVAC(2) Melanoma multi-antigen therapeutic vaccine
  • Intron A, Interferon alpha -2b
  • Tucson, Arizona
  • +18 more
Apr 12, 2016

Melanoma, Malignant Melanoma Trial in Israel, United States (CT-011)

Completed
  • Melanoma
  • Malignant Melanoma
  • New Haven, Connecticut
  • +17 more
Dec 16, 2015

Melanoma, Breast Cancer, Head and Neck Squamous Cell Cancer Trial in Pittsburgh (Vaccinia virus (vvDD-CDSR))

Completed
  • Melanoma
  • +5 more
  • Vaccinia virus (vvDD-CDSR)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Dec 23, 2015

Cancer, Melanoma Trial in United States (Sorafenib (Nexavar, BAY43-9006), Placebo, Dacarbazine)

Completed
  • Cancer
  • Melanoma
  • Sorafenib (Nexavar, BAY43-9006)
  • +2 more
  • Tucson, Arizona
  • +13 more
May 13, 2015

Fiber-optic Probe for Non-invasive Diagnosis of Melanoma and

Terminated
  • Melanoma
    • Pittsburgh, Pennsylvania
    • +2 more
    May 26, 2015

    Melanoma Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Carboplatin/Paclitaxel, Placebo)

    Completed
    • Melanoma
    • Sorafenib (Nexavar, BAY43-9006)
    • +2 more
    • Birmingham, Alabama
    • +65 more
    Oct 23, 2014

    Melanoma Trial in Worldwide (AZD6244, Temozolomide)

    Completed
    • Melanoma
    • Santa Monica, California
    • +32 more
    Aug 12, 2014

    Melanoma Trial in Worldwide (Elesclomol (STA-4783), Paclitaxel)

    Terminated
    • Melanoma
    • Tucson, Arizona
    • +100 more
    Jan 31, 2014

    Melanoma Trial in Worldwide (dacarbazine, CP-675,206, temozolomide)

    Completed
    • Melanoma
    • Huntsville, Alabama
    • +143 more
    Jun 25, 2012

    Melanoma, Skin Tumors Trial in France, United States (Axitinib [AG-013736])

    Completed
    • Melanoma
    • Skin Neoplasms
    • Axitinib [AG-013736]
    • Orange, California
    • +11 more
    Jun 21, 2012

    Melanoma Trial in United States (YM155)

    Completed
    • Melanoma
    • Tuscon, Arizona
    • +8 more
    Jun 6, 2012